Not sure why we don't sell our Priority Review vou
Post# of 72440
We got Fast Track and Priority Review during the
QIDP designation for BRIL,PR vouchers has turned into BIG Business
since the PR voucher is not tied to sponsor or product.
It has turned into a market of itself if you will.
One of the vouchers in 15' sold for $350M under
the rare pediatric disease designation.ABBV bought it off
United Therapeutics from United's Unituxin drug for
Neuroblastoma.
ABBV nvr did announce/or have to what drug it was
buying the voucher for!!!
LOL our voucher has to be worth something.
Cheers'